Search Results - "Wiechen, K"

Refine Results
  1. 1
  2. 2
  3. 3

    Two distinct functional effects of protein phosphatase inhibitors on guinea-pig cardiac L-type Ca2+ channels by Wiechen, K, Yue, D T, Herzig, S

    Published in The Journal of physiology (01-05-1995)
    “…1. The effects of the phosphatase inhibitors okadaic acid and calyculin A on single guinea-pig ventricular L-type Ca2+ channels were studied. The inactive…”
    Get full text
    Journal Article
  4. 4

    Suppression of the c-erbB-2 gene product decreases transformation abilities but not the proliferation and secretion of proteases of SK-OV-3 ovarian cancer cells by WIECHEN, K, KARAASLAN, S, TURZYNSKI, A, DIETEL, M

    Published in British Journal of Cancer (01-11-1999)
    “…The overexpression of the c-erbB-2 oncogene product has been reported in approximately 20-30% of human ovarian cancers and has been correlated with a poor…”
    Get full text
    Journal Article
  5. 5

    Diagnostic difficulties before definitive treatment of an extragonadal retroperitoneal germ cell tumor by Lassmann, J, Wille, A, Wiechen, K, Taupitz, M, Loening, S.A

    Published in Urology (Ridgewood, N.J.) (01-08-2001)
    “…A primary extragonadal germ cell tumor of the retroperitoneum was diagnosed in a 47-year-old man without elevated serum alpha-fetoprotein, human chorionic…”
    Get full text
    Journal Article
  6. 6

    Biochemical and electrophysiological mechanisms of the positive inotropic effect of calyculin A, a protein phosphatase inhibitor by Neumann, J, Bokník, P, Herzig, S, Schmitz, W, Scholz, H, Wiechen, K, Zimmermann, N

    “…Calyculin A (CyA; 1 microM) increased the force of contraction in isolated guinea pig papillary muscles to 144% of control without affecting contraction…”
    Get more information
    Journal Article
  7. 7

    Discordant results obtained for different methods of HER-2/neu testing in breast cancer: a question of standardization, automation and timing by LÜFTNER, D, HENSCHKE, P, KAFKA, A, ANAGNOSTOPOULOS, I, WIECHEN, K, GEPPERT, R, STEIN, H, WERNECKE, K. D, KREIENBERG, R, POSSINGER, K

    “…HER-2/neu positivity is required for the selection of stage IV breast cancer patients for trastuzumab therapy. We compared the results of the recommended…”
    Get full text
    Journal Article
  8. 8

    Caveolin-1 Is Down-Regulated in Human Ovarian Carcinoma and Acts as a Candidate Tumor Suppressor Gene by Wiechen, Kai, Diatchenko, Luda, Agoulnik, Alexander, Scharff, K. Michael, Schober, Hagen, Arlt, Katharina, Zhumabayeva, Bakhyt, Siebert, Paul D., Dietel, Manfred, Schäfer, Reinhold, Sers, Christine

    Published in The American journal of pathology (01-11-2001)
    “…To identify novel markers differentially expressed in ovarian cancer versus normal ovary, we hybridized microarrays with cDNAs derived from normal human…”
    Get full text
    Journal Article
  9. 9

    Loss of Gelsolin expression in human ovarian carcinomas by Noske, Aurelia, Denkert, Carsten, Schober, Hagen, Sers, Christine, Zhumabayeva, Bakhyt, Weichert, Wilko, Dietel, Manfred, Wiechen, Kai

    Published in European journal of cancer (1990) (01-02-2005)
    “…The ubiquitously expressed actin-binding protein, gelsolin, is known to play a role in the modulation of the actin network and in the regulation of cell growth…”
    Get full text
    Journal Article
  10. 10

    Down-Regulation of Caveolin-1, a Candidate Tumor Suppressor Gene, in Sarcomas by Wiechen, Kai, Sers, Christine, Agoulnik, Alexander, Arlt, Katharina, Dietel, Manfred, Schlag, Peter M., Schneider, Ulrike

    Published in The American journal of pathology (01-03-2001)
    “…Caveolae are plasma membrane microdomains that have been implicated in the regulation of several intracellular signaling pathways. Previous studies suggest…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14

    Antisense phosphorothioate oligodeoxynucleotide down‐regulation of the insulin‐like growth factor I receptor in ovarian cancer cells by Müller, Markus, Dietel, Manfred, Turzynski, Andreas, Wiechen, Kai

    Published in International journal of cancer (12-08-1998)
    “…The insulin‐like growth factors (IGF‐I and IGF‐II) play a key role in cellular proliferation and are involved in cellular transformation. The expression of the…”
    Get full text
    Journal Article
  15. 15

    Formalin-fixed blood clots--additional histological findings on computed tomography-guided fine-needle aspiration biopsies in comparison with core biopsies by Althoff, Christian E, Hermann, Kay-Geert A, Wiechen, Kai, Lembcke, Alexander, Enzweiler, Christian N H, Hamm, Bernd, Rogalla, Patrik

    Published in Journal of computer assisted tomography (01-05-2006)
    “…We investigated the diagnostic yield of histological examined formalin-fixed blood clots (FFBCs) in comparison with the established procedures of fine-needle…”
    Get full text
    Journal Article
  16. 16

    Selection of a high activity c-erbB-2 ribozyme using a fusion gene of c-erbB-2 and the enhanced green fluorescent protein by Wiechen, K, Zimmer, C, Dietel, M

    Published in Cancer gene therapy (01-01-1998)
    “…In different types of human cancer there is an overexpression of the c-erbB-2 (HER2/neu) oncogene, which is thought to be involved in tumor progression…”
    Get more information
    Journal Article
  17. 17

    Involvement of the c‐erbB‐2 oncogene product in the egf‐induced cell motility of sk‐ov‐3 ovarian cancer cells by Wiechen, Kai, Karaaslan, Selma, Dietel, Manfred

    Published in International journal of cancer (29-10-1999)
    “…The epidermal growth factor (EGF) induces the rapid formation of dendritic processes and the dissociation of SK‐OV‐3 ovarian cancer cells. The SK‐OV‐3 cell…”
    Get full text
    Journal Article
  18. 18

    The class II tumour suppressor gene H-REV107-1 is a target of interferon-regulatory factor-1 and is involved in IFN gamma -induced cell death in human ovarian carcinoma cells by Sers, C, Husmann, K, Nazarenko, I, Reich, S, Wiechen, K, Zhumabayeva, B, Adhikari, P, Schroeder, K, Gontarewicz, A, Schaefer, R

    Published in Oncogene (25-04-2002)
    “…H-rev107-1 is a growth inhibitory RAS target gene capable of suppressing anchorage independent growth in vitro and in vivo. Using a tumour tissue array with…”
    Get full text
    Journal Article
  19. 19
  20. 20